Susquehanna International Group’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-125,866
Closed -$11.6K 6773
2023
Q2
$11.6K Buy
+125,866
New +$11.6K ﹤0.01% 5421
2022
Q1
Hold
0
7002
2021
Q4
Sell
-43,445
Closed -$76K 6857
2021
Q3
$76K Buy
43,445
+1,513
+4% +$2.65K ﹤0.01% 5033
2021
Q2
$77K Buy
41,932
+29,615
+240% +$54.4K ﹤0.01% 5106
2021
Q1
$25K Sell
12,317
-1,071
-8% -$2.17K ﹤0.01% 5097
2020
Q4
$29K Buy
+13,388
New +$29K ﹤0.01% 4666
2020
Q3
Sell
-46,921
Closed -$185K 5309
2020
Q2
$185K Buy
+46,921
New +$185K ﹤0.01% 3751
2020
Q1
Hold
0
5391
2019
Q4
Hold
0
5296
2019
Q3
Hold
0
5358
2019
Q2
Hold
0
5341
2018
Q1
Sell
-699
Closed -$5K 5089
2017
Q4
$5K Sell
699
-3,612
-84% -$25.8K ﹤0.01% 3586
2017
Q3
$35K Buy
4,311
+2,169
+101% +$17.6K ﹤0.01% 2994
2017
Q2
$22K Sell
2,142
-1,842
-46% -$18.9K ﹤0.01% 3400
2017
Q1
$46K Buy
3,984
+2,679
+205% +$30.9K ﹤0.01% 3065
2016
Q4
$16K Sell
1,305
-8,442
-87% -$104K ﹤0.01% 4071
2016
Q3
$179K Sell
9,747
-731
-7% -$13.4K ﹤0.01% 2601
2016
Q2
$111K Buy
10,478
+7,520
+254% +$79.7K ﹤0.01% 2894
2016
Q1
$55K Sell
2,958
-304,989
-99% -$5.67M ﹤0.01% 3643
2015
Q4
$8.19M Sell
307,947
-3,440
-1% -$91.5K ﹤0.01% 517
2015
Q3
$14.2M Buy
311,387
+3,850
+1% +$176K 0.01% 358
2015
Q2
$9.9M Buy
307,537
+3,333
+1% +$107K ﹤0.01% 562
2015
Q1
$9.67M Sell
304,204
-11,990
-4% -$381K ﹤0.01% 504
2014
Q4
$12M Buy
316,194
+4,839
+2% +$183K ﹤0.01% 518
2014
Q3
$8.22M Sell
311,355
-6,101
-2% -$161K ﹤0.01% 668
2014
Q2
$9.4M Sell
317,456
-7,766
-2% -$230K ﹤0.01% 641
2014
Q1
$12M Buy
325,222
+273,558
+529% +$10.1M 0.01% 477
2013
Q4
$2.14M Buy
51,664
+40,191
+350% +$1.66M ﹤0.01% 1574
2013
Q3
$608K Sell
11,473
-6,199
-35% -$329K ﹤0.01% 2484
2013
Q2
$944K Buy
+17,672
New +$944K ﹤0.01% 2074